Antivirals

Antivirals

Biodefense Headlines – April 30, 2026

News Scan April 30, 2026

This week’s selections include cascading institutional disruptions reshaping U.S. public health and science governance — including the Trump administration’s mass firing of the National Science Board and restrictions on graduate…

RFP: Development of Novel Therapeutics for Select Pathogens

Researchers Closer to Countering Deadly Nipah Virus

Computation Leads to Better Understanding of Virus Replication

Notable Contracts: Mapp Biopharmaceutical, GSK, Battelle

Spanish Flu-Like Virus with Pandemic Potential Could Emerge

New Coronavirus Inhibitor Exhibits Potent Antiviral Activity

FDA Medical Countermeasures Initiative Symposium

Antibody Therapy Shows Promising Results for Chikungunya Virus

Screen of Drugs Finds Compounds Active against MERS

Scientists Find New Way to Mobilize Immune System against Viruses

RFI – Mechanism of Action for Ebola Countermeasures

Penn Vet Identifies Compounds That Control Hemorrhagic Viruses

Scientists Again Call for Delay in Destruction of Last Stocks of Smallpox

Researchers Find That Influenza Has an Achilles’ Heel

Scientists Identify Antibodies against Deadly Emerging MERS

How the Body Fights Against Viruses

Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered

Study: Ginseng Can Treat and Prevent Influenza, RSV

CEIRS Network to Integrate Research, Improve Pandemic Preparedness

Stockpiling Tamiflu a Waste of Money?

Biodefense Headlines – April 30, 2026